Pemetrexed-loaded nanoparticles targeted to malignant pleural mesothelioma cells: an in vitro study

Código QR

Pemetrexed-loaded nanoparticles targeted to malignant pleural mesothelioma cells: an in vitro study

Emanuela Cova,1 Laura Pandolfi,1 Miriam Colombo,2 Vanessa Frangipane,1 Simona Inghilleri,1 Monica Morosini,1 Simona Mrakic-Sposta,3 Sarah Moretti,3 Manuela Monti,4 Ymera Pignochino,5 Silvia Benvenuti,5 Davide Prosperi,2,6 Giulia Stella,1 Patrizia Morbini,7 Federica Meloni8 1Clinic of Lung Diseases,...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Cova E, Pandolfi L, Colombo M, Frangipane V, Inghilleri S, Morosini M, Mrakic-Sposta S, Moretti S, Monti M, Pignochino Y, Benvenuti S, Prosperi D, Stella G, Morbini P, Meloni F
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2019
Materias:	Gold nanoparticles nano-drug delivery mesothelioma pemetrexed intrapleural delivery Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/0f3cb39b00e94184981238b22cad5483
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Modern management of malignant pleural mesothelioma
por: Patel SC, et al.
Publicado: (2016)

Intestinal transport mechanism and in vivo anticancer efficacy of a solid oral formulation incorporating an ion-pairing complex of pemetrexed with deoxycholic acid derivative
por: Pangeni R, et al.
Publicado: (2019)

Malignant Pleural Mesothelioma Nodal Status: Where Are We at?
por: Sara Ricciardi, et al.
Publicado: (2021)

Extended Pleurectomy/Decortication for Malignant Pleural Mesothelioma: Humanitas’s Experience
por: Giuseppe Mangiameli, et al.
Publicado: (2021)

A pilot study of zoledronic acid in the treatment of patients with advanced malignant pleural mesothelioma
por: Jamil MO, et al.
Publicado: (2017)

65Plus: open-label study of bevacizumab in combination with pemetrexed or pemetrexed/carboplatin as first-line treatment of patients with advanced or recurrent nonsquamous non-small-cell lung cancer
por: Schuette W, et al.
Publicado: (2017)

Experiencia con la penicilina
por: ORTEGA,RAUL, et al.
Publicado: (1946)

The role of radiation therapy in the treatment of patients with pleural mesothelioma
por: Tatiana N. Borisova, et al.
Publicado: (2021)

Development of liposomal pemetrexed for enhanced therapy against multidrug resistance mediated by ABCC5 in breast cancer
por: Bai F, et al.
Publicado: (2018)

Clinical staging of malignant pleural mesothelioma: current perspectives
por: Bonomi M, et al.
Publicado: (2017)

Can intrapleural alteplase treatment be an alternative to videothoracoscopic deloculation and decortication in pleural empyema?
por: Tayfun Kermenli, et al.
Publicado: (2021)

Correlation between MTHFR 677C > T polymorphism and response of pemetrexed-based chemotherapy in advanced NSCLC: A meta-analysis
por: Han Feng, et al.
Publicado: (2021)

MALAT1 promotes malignant pleural mesothelioma by sponging miR-141-3p
por: Wang Pei, et al.
Publicado: (2021)

Correlation between immune-related adverse events and therapeutic effects of nivolumab in patients with malignant pleural mesothelioma
por: Hiroto Yoneda, et al.
Publicado: (2021)

Serum Calretinin as a Biomarker in Malignant Mesothelioma
por: Cita Zupanc, et al.
Publicado: (2021)

The Epithelial-to-Mesenchymal Transition (EMT) in the Development and Metastasis of Malignant Pleural Mesothelioma
por: Valeria Ramundo, et al.
Publicado: (2021)

Metronomic delivery of orally available pemetrexed-incorporated colloidal dispersions for boosting tumor-specific immunity
por: Ruby Maharjan, et al.
Publicado: (2021)

Pilot Study to Evaluate Serum Soluble Mesothelin-Related Peptide (SMRP) as Marker for Clinical Monitoring of Pleural Mesothelioma (PM): Correlation with Modified RECIST Score
por: Federica Grosso, et al.
Publicado: (2021)

A novel PDX modeling strategy and its application in metabolomics study for malignant pleural mesothelioma
por: Zhongjian Chen, et al.
Publicado: (2021)

Mesothelioma with Nonbacterial Thrombotic Endocarditis: A Case Report
por: Avatar Verma, et al.
Publicado: (2021)

Early Response to Chemotherapy in Malignant Pleural Mesothelioma Evaluated Using Diffusion-Weighted Magnetic Resonance Imaging: Initial Observations
por: Sebastian Curcean, M.B.B.S., et al.
Publicado: (2021)

Anti-Ma2-Associated Limbic Encephalitis after Termination of Immune Checkpoint Inhibitor Therapy for Malignant Pleural Mesothelioma
por: Rei Hashimoto, et al.
Publicado: (2021)

A preliminary study: is fibulin 1 a friend or an enemy that needs to be silenced with siRNAs for mesothelioma?
por: Asude Aksoy, et al.
Publicado: (2021)

Pain management in patients with malignant mesothelioma: challenges and solutions
por: Saunders J, et al.
Publicado: (2019)

Enhanced oral absorption of pemetrexed by ion-pairing complex formation with deoxycholic acid derivative and multiple nanoemulsion formulations: preparation, characterization, and in vivo oral bioavailability and anticancer effect
por: Pangeni R, et al.
Publicado: (2018)

Diagnostic and Prognostic Value of Three microRNAs in Environmental Asbestiform Fibers-Associated Malignant Mesothelioma
por: Veronica Filetti, et al.
Publicado: (2021)

Mesothelioma Malignancy and the Microenvironment: Molecular Mechanisms
por: Francesca Cersosimo, et al.
Publicado: (2021)

Prolonged retention of liposomes in the pleural cavity of normal mice and high tumor distribution in mice with malignant pleural effusion, after intrapleural injection
por: Marazioti A, et al.
Publicado: (2019)

Differential diagnosis and treatment of primary peritoneal cancer and mesothelioma
por: Amir G. Abdullaev, et al.
Publicado: (2021)

Diagnostic and Prognostic Utility of the Extracellular Vesicles Subpopulations Present in Pleural Effusion
por: Joman Javadi, et al.
Publicado: (2021)

Preclinical Models and Resources to Facilitate Basic Science Research on Malignant Mesothelioma – A Review
por: Ben William Johnson, et al.
Publicado: (2021)

JME-001 phase II trial of first-line combination chemotherapy with cisplatin, pemetrexed, and nivolumab for unresectable malignant pleural mesothelioma
por: Nobukazu Fujimoto, et al.
Publicado: (2021)

Malignant Peritoneal Mesothelioma With EWSR1-ATF1 Fusion: A Case Report
por: Helen Ke, MBBS (Hons), et al.
Publicado: (2021)

A case of nonislet cell tumor hypoglycemia associated with malignant mesothelioma requiring a multifaceted approach for optimal glycemic control
por: Mariko Ono, et al.
Publicado: (2021)

Efficacy of Intraoperative Hypertonic Glucose Solution Administration on Persistent Air Leak After Extended Pleurectomy/Decortication for Malignant Pleural Mesothelioma: A Retrospective Case–Control Study
por: Alberto Testori, et al.
Publicado: (2021)

Communicating imaging findings in peritoneal mesothelioma: the impact of ‘PAUSE’ on surgical decision-making
por: Anuradha Chandramohan, et al.
Publicado: (2021)

The Safety and Exploration of the Pharmacokinetics of Intrapleural Liposomal Curcumin
por: Hocking A, et al.
Publicado: (2020)

Multimodal Diagnostic Workup of Primary Pericardial Mesothelioma: A Case Report
por: Jiahui Liu, et al.
Publicado: (2021)

Composite non-clinical interventions for a safe cesarean section rate reduction: results of a pre-post interventional study
por: A. Fruscalzo, et al.
Publicado: (2021)

American journal of drug delivery
Publicado: (2003)